BIVI - CIK 0001580149
The table below shows BIOVIE INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.54M | $23.84M | $19.46M | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $20.70M |
| $24.05M |
| $34.04M |
| $18.78M |
| $4.61M |
| $412.98K |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $345.71K | $345.71K | $345.71K | $345.71K | $345.71K | $345.71K |
| Total assets | $21.56M | $25.21M | $35.10M | $20.11M | $6.05M | $2.08M |
| Accounts payable | $2.20M | $3.59M | $3.48M | $2.44M | $996.37K | $1.26M |
| Total current liabilities | $2.27M | $9.35M | $14.49M | $4.17M | $996.37K | $23.52M |
| Long-term debt | - | - | - | - | $62.50K | $62.50K |
| Total liabilities | $2.55M | $9.70M | $19.76M | $16.44M | $996.37K | $23.58M |
| Retained earnings | -$352.14M | -$334.23M | -$301.23M | -$250.97M | -$224.89M | -$41.04M |
| Total equity | $19.01M | $15.51M | $15.34M | $3.67M | $5.05M | -$21.50M |